Project Grant R01HL177297
Award Date
1/17/25
Completion Date
11/30/29
Dollars Obligated
$696K
Federal Agency
National Heart Lung and Blood Institute
Federal Grant Program
93.837
Assistance Type
Project Grant
Place of Performance
Denver, CO 80210, USA
Similar Awards
The National Heart, Lung, and Blood Institute (NHLBI) awarded a $2,111,497 Project Grant (CFDA 93.837 - Cardiovascular Diseases Research) to Mayo Clinic in Rochester, Minnesota. The 5-year grant, commencing on May 1, 2024, will investigate the effects of experimental sleep restriction on blood pressure and cardiovascular function in individuals with a positive parental history of hypertension compared to those with a negative parental history. The study aims to explore the role of sleep...
This federal Project Grant award from the National Heart, Lung, and Blood Institute (NHLBI), under the Cardiovascular Diseases Research (CFDA 93.837) program, will provide $752,991 to the University of Cincinnati to conduct research on early childhood sleep health disparities. The project aims to evaluate how factors such as racism, housing insecurity, screen media use, and toxic stress impact sleep health in young children aged 20-48 months, and how these multilevel socioeconomic and...
The National Heart, Lung, and Blood Institute (NHLBI) awarded a 5-year, $647,174 Project Grant under the Cardiovascular Diseases Research (CFDA 93.837) program to The Miriam Hospital to investigate the long-term effects of prenatal mindfulness training on maternal and infant cardiovascular disease risk. The study will follow 130 participants and their infants enrolled in a parent randomized controlled trial, measuring the impact of the prenatal mindfulness intervention on postpartum maternal...
The National Heart, Lung, and Blood Institute (NHLBI) of the National Institutes of Health (NIH) awarded a $133,410 Project Grant (R21HL175584) under the Cardiovascular Diseases Research program (CFDA 93.837) to the University of Massachusetts Medical School to investigate the impact of sleep pathology on cardiac aging. The 2-year research project, running from September 2024 to August 2026, will leverage a large longitudinal dataset to assess the association between sleep apnea and cardiac...
The University of Michigan was awarded a $691,124 Project Grant from the National Heart, Lung, and Blood Institute (NHLBI) under the Cardiovascular Diseases Research program (CFDA 93.837). The grant aims to test the hypothesis that persistent circadian disruption, including misaligned sleep, eating, and activity timing, will be related to the development of cardiometabolic risk from adolescence to young adulthood. The project will leverage existing objective sleep/wake pattern and...
This is a Project Grant award from the National Heart, Lung, and Blood Institute (NHLBI) under the Cardiovascular Diseases Research federal grant program (CFDA 93.837). The $660,540 award to the University of South Carolina will fund research to investigate the role of kynurenic acid (KYNA) in disrupting maternal sleep and impacting neurocognitive outcomes in offspring. The key objectives are to: 1) Define sleep problems during pregnancy when KYNA formation is upregulated, and assess whether...
The National Heart, Lung, and Blood Institute (NHLBI) awarded Auburn University a $460,920 Project Grant under the Cardiovascular Diseases Research program (CFDA 93.837) to investigate the processes underlying the connection between racial discrimination and sleep problems. The project aims to determine how discrimination triggers emotion invalidation, termed "social pain minimization", which negatively impacts sleep quality. The researchers will use daily ecological momentary...
This Project Grant award in the amount of $2,428,701.00 was issued by the National Heart, Lung, and Blood Institute (NHLBI) under the Cardiovascular Diseases Research program (CFDA 93.837). The award will fund a prospective evaluation of 1,000 pregnant individuals (40% minorities) with cardiovascular disease to identify patient characteristics, clinical outcomes, and structural care components associated with adverse pregnancy, maternal, and neonatal outcomes. The study aims to address the...
This Project Grant award from the National Heart, Lung, and Blood Institute (NHLBI) under the Cardiovascular Diseases Research program (CFDA 93.837) provides $821,982 in funding to The Trustees of Columbia University in the City of New York to investigate the relationship between variability in sleep timing and cardiovascular disease (CVD) risk among women. The research aims to: 1) analyze the link between objectively-measured variable sleep timing and CVD risk factors, examining potential...
The National Heart, Lung, and Blood Institute (NHLBI), through the Cardiovascular Diseases Research federal grant program (CFDA 93.837), awarded the Icahn School of Medicine at Mount Sinai (ISMMS) a $777,954 Project Grant to conduct a mixed-method study focused on identifying school policy interventions to improve adolescent cardiovascular health and reduce racial/ethnic disparities in maternal health outcomes. The study will construct a school-based adolescent preconception cohort, engage...